KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Fulgent Genetics (FLGT) Other Gross PP&E Adjustments (2016 - 2026)

Fulgent Genetics' Other Gross PP&E Adjustments history spans 12 years, with the latest figure at $155.3 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments changed 0.01% to $155.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $155.3 million, a 0.01% change, with the full-year FY2025 number at $150.6 million, up 0.52% from a year prior.
  • Other Gross PP&E Adjustments hit $155.3 million in Q1 2026 for Fulgent Genetics, up from $150.6 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for FLGT hit a ceiling of $160.2 million in Q2 2025 and a floor of $82.5 million in Q1 2022.
  • Historically, Other Gross PP&E Adjustments has averaged $128.9 million across 5 years, with a median of $130.7 million in 2024.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 48.23% in 2022 and later increased 0.01% in 2026.
  • Tracing FLGT's Other Gross PP&E Adjustments over 5 years: stood at $107.3 million in 2022, then grew by 9.26% to $117.2 million in 2023, then rose by 27.82% to $149.8 million in 2024, then grew by 0.52% to $150.6 million in 2025, then increased by 3.13% to $155.3 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for FLGT at $155.3 million in Q1 2026, $150.6 million in Q4 2025, and $159.1 million in Q3 2025.